Clinical Trial Update: Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (RED-HEART) is evaluating riociguat for its effects on the right heart in chronic thromboembolic pulmonary hypertension (CTEPH). The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (Adempas) (riociguat)

Snippet

Sponsor: Suqiao Yang | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Status: RECRUITING